Zeneca Pharmaceuticals
Alderley Park, Macclesfield, Cheshire, UK

Presentations

• Phil Arundal (Zeneca, UK)
  Use of Animal Data to Predict Kinetics in Man using Physiological Models
• Chris Murray and Tim Auton (Proteus, UK)
  Use of Bayesian Methods to improve the quality of an empirical scoring function for predicting binding energy
• Martin Bayliss (Glaxo-Welcome, UK)
  The Application of Multiple Compound (N in one) pharmacokinetic studies in modifying our approach to the drug discovery and lead optimisation process
• Martin Brown (Institute of Speech and Intelligent Systems, Southampton University, UK)
  Fuzzy and Neurofuzzy Method
• Clair Ginn (Dept of Information Studies Sheffield University, UK)
  The Application of Data Fusion to Similarity Searching of Chemical Databases
• Mike Stubbins (Glaxo-Welcome, UK)
  Genetic polymorphisms in human drug metabolising enzymes: The identification, verification and possible consequences of single nucleotide substitutions on enzymatic function and on disease susceptibility